Challenges in Treating Hepatitis C in Injection Drug Users
Author Information
Author(s): Cooper Curtis L, Mills Edward J
Primary Institution: University of Ottawa Hospital, Division of Infectious Diseases
Hypothesis
What are the therapeutic challenges faced by hepatitis C-infected injection drug users?
Conclusion
HCV treatment for injection drug users is complicated by mental health issues, substance abuse, and socioeconomic factors.
Supporting Evidence
- Injection drug use is the primary risk factor for new and chronic HCV infections in North America.
- Concurrent alcohol use is found in 40% of active injection drug users.
- 75% of past injection drug users have a history of excess alcohol use.
Takeaway
People who use drugs and have hepatitis C have a hard time getting treatment because of their health and living situations.
Potential Biases
Potential bias due to the stigma associated with injection drug use and mental health issues.
Limitations
The study does not provide strong evidence for all claims and relies on observational data.
Participant Demographics
The study focuses on injection drug users, particularly in North America.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website